Authors:
Caronia, S
Bassendine, MF
Barry, R
Mills, P
Naoumov, NV
Fox, R
Lowes, J
Hollanders, D
Murray-Lyon, L
Irving, WL
Goldin, RD
Foster, GR
Citation: S. Caronia et al., Interferon plus amantadine versus interferon alone in the treatment of naive patients with chronic hepatitis C: a UK multicentre study, J HEPATOL, 35(4), 2001, pp. 512-516
Authors:
Paterson, M
Laxton, C
Goldin, RD
Ackrill, AM
Foster, GR
Citation: M. Paterson et al., Selection of HCVNS5A quasispecies during IFN therapy in patients with chronic HCV, DIG DIS SCI, 46(7), 2001, pp. 1399-1408
Authors:
Leyland, M
Torok, ME
Acheson, J
Foster, GR
Citation: M. Leyland et al., Hepatitis C virus infection is not associated with a marked increase in the prevalence of ophthalmic morbidity, EYE, 14, 2000, pp. 889-891
Authors:
Ward, C
Tudor-Williams, G
Cotzias, T
Hargreaves, S
Regan, L
Foster, GR
Citation: C. Ward et al., Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing, GUT, 47(2), 2000, pp. 277-280
Authors:
Foster, GR
Germain, C
Jones, M
Lechler, RI
Lombardi, G
Citation: Gr. Foster et al., Human T cells elicit IFN-alpha secretion from dendritic cells following cell to cell interactions, EUR J IMMUN, 30(11), 2000, pp. 3228-3235
Citation: L. Hibbert et Gr. Foster, Human type I interferons differ greatly in their effects on the proliferation of primary B cells, J INTERF CY, 19(4), 1999, pp. 309-318
Citation: Hc. Thomas et al., Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon alfa therapy - Comments, HEPATOLOGY, 29(4), 1999, pp. 1333-1334
Authors:
Paterson, M
Laxton, CD
Thomas, HC
Ackrill, AM
Foster, GR
Citation: M. Paterson et al., Hepatitis C virus NS5A protein inhibits inteferon antiviral activity, but the effects do not correlate with clinical response, GASTROENTY, 117(5), 1999, pp. 1187-1197